New biosimilar dupilumab Look-Alike tested in healthy volunteers
NCT ID NCT07334496
First seen Jan 12, 2026 · Last updated Apr 25, 2026 · Updated 18 times
Summary
This study checks if a new medicine called GLR1044 works the same as the approved drug Dupilumab (Dupixent®). It involves 198 healthy Chinese men who get one injection of either the new or the original drug. Researchers measure how the drug moves in the body and watch for side effects over about two months. This is an early-stage study to confirm the new drug is similar before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOSIMILARITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Gobroad Hospital
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.